Fr. 78.00

PHYTOCHEMICAL STUDIES IN Corynandra chelidonii - ANTICANCER ANALYSIS IN Corynandra chelidonii. DE

English · Paperback / Softback

Shipping usually within 2 to 3 weeks (title will be printed to order)

Description

Read more

One of the important ethno medicinal herb-Corynandra chelidonii was recently reported new species from India, Cleome chelidonii belongs to Cleomaceae family according to latest APG classification. It was the rare, endemic important Ethnomedicinal herb. Phytochemical analysis for the presence of secondary metabolites and their pharmacological activities studied. Identified novel therapeutic compounds by GC-MS analysis. Determined of antioxidant activity by DPPH Assay. Preliminary investigation by MTT ASSAY for the presence of anticancer activity. GC-MS analysis results reported 4 compounds which are identified as the first report from Corynandra chelidonii. They are namely,2,2,2-Trichloro-1-(2- nitrophenylthioamino) ethanol, N,N'-Bis (piperonylidene) ethylenediamine, 3'-methoxy-2,2'- dinitro- Phenylethylene, and Cycloprop-2-enecarbonic acid, 2-(2-propenyl)-methyl ester. The free radical scavenging activity of ethanolic extract of this has potent antioxidant activity with half maximum concentration IC50 as 66.97. The scavenging activity was increased in a dose dependant manner ( which initiated with 5µg and reached to 88% at 500µg/ml.

Product details

Authors BEGARI MADHURIKA, S. Karnakar Reddy
Publisher LAP Lambert Academic Publishing
 
Languages English
Product format Paperback / Softback
Released 29.05.2025
 
EAN 9786208448219
ISBN 9786208448219
No. of pages 120
Subject Natural sciences, medicine, IT, technology > Medicine > Holistic medicine

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.